Immunotherapy of cancer with interleukin-2 and lymphocytes (LAK or TIL).
Parmiani
G
G
Division of Experimental Oncology D, Istituto Nazionale Tumori, Milan, Italy.
D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D008214:Lymphocytes / Q000276:immunology*; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2